Symbiotec Pharmalab Limited, a company with a strong global leadership position in Corticosteroid and Steroidal Hormone Active Pharmaceutical Ingredients, plans to raise INR 1,757 crore through an IPO. [Fresh Issue ₹150 Cr + OFS ₹1,607 Cr] Symbiotec Pharmalab IPO price: ₹938–₹988 per share Symbiotec Pharmalab: History The Company was incorporated as Symbiotec Pharmalab Private… Continue reading Symbiotec Pharmalab IPO Review